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Abstract
Background: To achieve health development goals, policymakers are increasingly focused on improving primary
care in low- and middle-income countries, and private sector drug retailers offer one channel through which basic
services may be delivered. In Nigeria, patent and proprietary medicine vendors (PPMVs) serve as a main source of
medications, but little is known about their clientele or how care is sought at PPMVs for common illnesses. We explore
differences in care-seeking at PPMV shops based on the most commonly reported symptoms.
Methods: In Kogi and Kwara states, Nigeria, 250 PPMV shop workers and 2,359 customers purchasing drugs were
surveyed, and each worker-customer interaction was observed. Multivariate regression analysis was used to assess
the association of commonly reported symptoms with care-seeking behavior prior to attending the shop and
while interacting with the provider at the shop.
Results: Most customers sought care for headache (30.5 %), fever (22.9 %), cough/cold (18.1 %), or diarrhea (8.4 %).
Customers with fever were more likely to report being diagnosed by a formally trained person, to have discussed the
illness with and be examined by the shop worker, and have more difficulty paying. In contrast, customers with
headache symptoms were less likely to experience these outcomes and spent less money purchasing drugs.
Those reporting cough or cold symptoms were less likely to have been diagnosed by a formally trained person,
waited longer before visiting the PPMV shop, and were more likely to discuss the illness with the shop worker, but
were less likely to be examined or to recommend the purchased drug themselves. If a sick child was brought to
the shop, a discussion of the illness and an exam were more likely and more money was spent on drugs.
Conclusions: Because care-seeking behaviors vary by symptoms and the sick person’s age, PPMVs should be trained
to treat common illnesses for which customers are unlikely to seek a formal medical consultation. Interventions aimed
at improving primary care need to target the places where most people access care, and equip PPMV workers with
knowledge and tools to provide basic services.
Keywords: Care-seeking behavior, Customer interaction, Drug shops, Fever, Headache, Patent and proprietary medicine
vendors, Nigeria
Background
In order to achieve universal health coverage, expanded
access to basic primary care services is needed, especially
in low- and middle-income (LMIC) countries [1]. Al-
though access to care and child survival have improved
over the last three decades [2, 3], many people in LMICs
continue to face a variety of structural and social barriers
to obtaining formal primary care services [4], resulting
in inequitable access [1].
Across many countries in Sub-Saharan Africa (SSA), a
large portion of care is delivered through private sector
providers, ranging from traditional healers and informal
providers to formally trained nurses, midwives, and cli-
nicians [5]. In many instances, the point of first care-
seeking occurs at drug shops whose workers may not
necessarily be formally trained in healthcare provision,
and thus often act as informal providers. For example,
private drug shops are the first place where treatment is
sought for common childhood illnesses for between 15 %
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and 83 % of episodes in different SSA countries [6]. Given
their numbers, market share, and presence in rural com-
munities, drug shops represent an important opportunity
for improving primary health care, and several SSA coun-
tries have included drug retailers in national health inter-
ventions [7–9].
In Nigeria, patent and proprietary medicine vendors
(PPMVs), defined as “a person without formal training
in pharmacy who sells orthodox pharmaceutical prod-
ucts on a retail basis for profit” [10], provide the main
source of medicine for many common illnesses. The es-
timated 200,000 PPMVs operating in Nigeria [11] are
the first source of care for up to 55 % of under-five child
illnesses, such as malaria and diarrhea, and 35 % to 55 %
of adult malaria treatment [12–16]. In addition to selling
drugs, PPMVs can be a source of advice about illness
and drug therapy [17] in place of more formal care at
health facilities, even if they are relatively accessible.
Legally, PPMVs are permitted to sell a limited number
of pre-packaged, over-the-counter medicines, but are
prohibited from selling prescription medications (e.g. an-
tibiotics) or conducting invasive medical procedures (e.g.
malaria rapid diagnostic tests) [18]. Formal medical or
pharmacy training is not required for PPMV licensure
[17], but by convention, the minimum educational at-
tainment has been primary schooling [10] and most
complete an apprenticeship with a more senior PPMV
before opening their own shop [19, 20]. Because the pri-
mary function of a PPMV shop is retail sales and not
healthcare, customer demand often dictates the products
and services provided [10], and may lead to PPMVs
practicing beyond their legal scope [21–24].
A recent systematic review of PPMV practices shows that
PPMVs provide medicines and services for a wide variety of
health needs, including malaria, respiratory infections, diar-
rhea, common cough and cold, tuberculosis, and repro-
ductive health; however, the quality of these services is low
[25]. PPMVs generally have low health knowledge and poor
health treatment practices, stock poor quality medicines
(e.g. partial or repackaged doses [26], and sub-standard for-
mulations [27, 28]) as well as medicines and commodities
they are prohibited from selling [21–24]. While the litera-
ture is dominated by studies of malaria, the available evi-
dence indicates that PPMVs’ limited knowledge of proper
treatment practices contributes to sales of inappropriate, in-
effective, and incorrect drugs for many health problems.
The review also highlighted the lack of information about
the full range of services offered at PPMVs as most studies
focused on a single health focus; with a few notable excep-
tions, little is known about the spectrum of conditions that
customers seek treatment for, how PPMVs interact with
customers in order to dispense medications for those con-
ditions [10, 21], and the variety of drugs sold at PPMV
shops.
In order to fill these gaps, the aim of this paper is to
explore differences in care-seeking behavior based on
the type of symptoms most commonly reported (fever,
headache, diarrhea, or cough/cold) by PPMV shop cus-
tomers. We investigate two sets of outcomes: (1) care-
seeking behavior in terms of getting diagnosed by a for-
mally trained person prior to attending the PPMV shop,
and time waited before attending the PPMV shop; and
(2) PPMV-customer interactions based on whether or
not the illness was discussed, conduct of an exam on the
sick person, who recommended the drug dispensed, cost
of treatment, and self-reported difficulty in paying. Find-
ings are discussed in light of policy considerations that
seek to improve the quality of primary care services by
PPMVs for the most common health conditions.
Methods
Study area and sample selection
The study was conducted in Kogi and Kwara states in
the North Central geopolitical zone of Nigeria. Kogi
State, located in central Nigeria just south of the Federal
Capital Territory and comprised of 21 local government
areas (LGAs) over 30,355 km2, houses about 4.0 million
people from a diverse ethnic background, among which
the Igala and Ebira tribes have the largest representation
[29]. Kwara State, lying to the east of Kogi, is more
sparsely populated with about 2.4 million people residing
in 15 LGAs over 32,500 km2 [30]. The principal tribal
groups are the Yoruba, but Nupe, Bariba and Fulani are
also present. In both states, agriculture forms the basis
of the economy (e.g. cassava, yams, rice, cotton, coffee),
but mining activities also contribute. At US$1,386 and
US$1,585, Kogi and Kwara rank 24th and 20th, respect-
ively, among Nigeria’s 36 states and the Federal Capital
Territory in terms of per capita gross domestic product
[31].
From April to September 2013, all PPMV retail estab-
lishments selling drugs in the study states were enumer-
ated. From a complete listing of 2,083 shops (1,088 in
Kogi, 995 in Kwara), 250 were selected (125 per state)
for this study through a modified, stratified random sam-
pling approach: due to security concerns and logistical chal-
lenges, the sampling of PPMV shops was centered around
four focal urban or peri-urban hubs in each state (Kogi:
Ayangba, Ida, Lokoja, and Okene; Kwara: Ajase-Ipo,
Bode-Sadu, Ilorin, and Omu-Aran). Shops within a 25-km
radius (the distance that a surveyor could safely and feas-
ibly travel to and from a central post in one day in each
hub, chosen in consultation with local officials) from the
hub center were randomly selected, stratified across urban,
peri-urban, and rural locations.
All PPMV shops chosen in the sampling process from
the census were eligible to participate. From Monday to
Saturday, each surveyor (two if multiple local language
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capabilities were needed) visited one shop per day, arriving
at opening hours and leaving when the shop closed at
night. If a shop could not be located (due to absent pro-
vider, closure, or incorrect address), a shop in the vicinity
that self-identified as a PPMV and was not chosen in the
original sample was randomly selected as a replacement
(30 in Kogi, 24 in Kwara). Shop workers were not given
advance notice of a visit. Upon arrival at the shop, written
informed consent was obtained from the person in charge
at the time (79.2 % owner, 6.8 % manager, 13.2 % appren-
tice, 0.8 % other). All shops approached for consent agreed
to participate.
Data collection
Two data collection activities took place at each shop:
(1) a shop survey and (2) customer observations and exit
interviews. Shop surveys were administered at the begin-
ning of the day when customer traffic was lower, but in-
terruptions for attending to customers were allowed.
The shop survey captured information about the shop
owner’s and workers’ sociodemographic characteristics,
knowledge of and self-reported practices for treating
common childhood illnesses (malaria, diarrhea, and
pneumonia), social and institutional resources for drug
and healthcare advice, and types of drugs stocked. At
the end of the day, the shop worker was given a small
gift—a wall clock valued at 500 Naira (~US$3.13)—as
compensation for participation.
Throughout the day, surveyors recorded observations
for all customers coming to the shop according to a
standardized form. These included time of visit, waiting
time, with whom the customer interacted, and topics of
discussion (e.g. history of illness, symptoms experienced,
drugs needed to treat the illness, prevention information,
referral), whether any examination (physical or other-
wise) was conducted, and whether any drugs were pur-
chased. Surveyors did not engage with either the shop
worker or the customer during an interaction. If cus-
tomers purchased a drug, s/he was approached after
leaving the shop to obtain verbal informed consent, ver-
ify eligibility, and be administered the exit survey. Only
customers over age 12 were eligible, the minimum age
for giving informed consent commensurate with the
study’s minimal risk level as determined in consultation
with local officials and approved by the local Institu-
tional Review Board. The exit interview captured the
sociodemographic characteristics of the customer and
the sick person, symptoms experienced and being
treated, source of illness recognition, types of drugs pur-
chased, and amount spent. On average, customer obser-
vations took less than five minutes and exit interviews
about four minutes. During times of high customer vol-
ume, some customers were missed and surveyors re-
corded the number of customers missed while they were
occupied with an exit interview. No personally identify-
ing information for customers was recorded and no
compensation was given. Among 5,123 customer obser-
vations recorded, 3,014 (59.1 %) purchased a drug, of
whom, 2,442 (81.0 %) completed an exit interview.
Care-seeking behavior
Customer care-seeking behavior was operationalized as
two measures: (1) having been diagnosed by a formally
trained person and (2) time waited before visiting the
PPMV shop since the onset of symptoms. Customers are
coded as being diagnosed by a formally trained person if
they responded to the question, “Who figured out what
illness this is?” with responses of doctor/nurse, pharma-
cist, or community health extension worker (CHEW);
responses of myself/relative/friend, chemist/PPMV, trad-
itional healer, or lab technician were coded as not being
diagnosed by a formally trained person. Time waited be-
fore attending the PPMV shop was self-reported by the
customer and coded as a binary indicator (0-1 day vs. 2
or more days); additional ways of coding of this variable
(i.e. continuous, ordered count) produced similar results.
Shop interaction and drug purchase outcomes
Shop interactions were characterized with three binary vari-
ables. (1) Whether or not the customer and PPMV dis-
cussed the illness was based on observation, coded 1 if the
symptoms or recent history of illness were mentioned by
either the shop worker or the customer during the inter-
action. (2) Whether or not the sick person was physically
examined was determined by the surveyor if s/he observed
that any conduct of an “exam” occurred, which included
looking at physical appearance, inspecting parts of the
body, measuring blood pressure or temperature, or check-
ing eye color. (3) Whether or not the customer, a family
member, or a friend recommended the drug purchased was
based on answers to the question, “Who mainly recom-
mended the drugs that you purchased today?” and coded
as 1 if the response was “myself” or “family/friends” and 0
for responses of “doctor/nurse”, “pharmacist”, “chemist/
PPMV”, “CHEW”, or “traditional healer”.
Two cost-related outcomes were constructed: (1) total
cost in Naira and (2) whether or not the customer had
problems paying. In the exit interview, customers were
asked, “How much did all of this cost?” for the drugs
purchased (excluding any other commodities). A follow-
up question probed about whether or not s/he had prob-
lems paying for the drugs purchased.
Data analysis
Multivariate analyses were performed using logistic re-
gression for all outcomes except for drug cost, which
was log-transformed and analyzed using linear regres-
sion. Standard errors were clustered by drug shop to
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account for autocorrelation among customers attending
the same shop. Covariates for PPMV shop worker and
customer characteristics were selected based on a priori
hypotheses of determinants of care-seeking. Shop worker
characteristics included age (years), gender, formal med-
ical training (coded as 1 if self-reported as a pharmacist,
nurse, midwife, doctor, or CHEW and 0 if self-reported
as a current apprentice, completed apprentice, lab techni-
cian, or none), reported offering tests or exams (e.g. taking
temperature with a thermometer, measuring blood pres-
sure, checking eyes, or performing a physical exam), loca-
tion (urban, peri-urban, or rural), and state. Customer
characteristics included gender, age (i.e. age 13-18, 19-25,
26-40, or 41 and over), highest education completed
(primary, secondary, or more than secondary), tribe, liv-
ing in the community where the PPMV shop is located,
having a clinic near his/her home (allowing the cus-
tomer to self-define “near”), age of the sick person (i.e.
under age 5, 5-17, or 18 and over), if the sick person is a
child (i.e. age 18 or under) and male, if the sick person
is a child and present at the PPMV shop, and the most
commonly self-reported symptoms (i.e. fever, diarrhea,
headache, or cough/cold including congestion, cough,
cold, or sore throat). Symptoms reported in low fre-
quencies (e.g. sweating, nausea/vomiting, shortness of
breath, body aches/joint pain, dizziness/lightheaded,
dark urine, or chills/shivering) were not included as
they did not logically aggregate into larger categories.
Wealth index quintiles were constructed using standard
principal components analysis of household asset indi-
cators [32] and were included in all multivariate
analyses.
Interactions were explored to investigate differential ef-
fects according to (1) the degree of concordance between
the PPMV and the customers’ tribal affiliation; (2) gender
with the age of the sick child; (3) wealth status with the
gender of the sick child; (4) wealth status with source of
diagnosis; and (5) the experience of fever symptoms with
age of the sick child. None of these interactions were sig-
nificant and were excluded in the final analyses.
The type of drug purchased (e.g. ACT, other antimal-
arial, antibiotic, anti-diarrheal, analgesic, or vitamin/
supplements) per customer was descriptively analyzed
according to reported symptoms. P-values were consid-
ered significant if p < 0.05. Analysis was performed
using StataSE version 13.1.
Ethical considerations
The Nigerian Health Research Ethical Review Committee
approved this study. Verbal informed consent was ob-
tained from customers and written informed consent from
shop workers. Funding sponsors did not have any role in
the study design, execution, or publication.
Results
Customer characteristics
A total of 2,359 customers over age 12 agreed to complete
an exit interview after purchasing a drug from a sampled
shop. About half (52.3 %) were male and 15.8 % were chil-
dren (age 13-18; see Table 1). Nearly half (46.7 %) had
completed secondary education. While customers came
from several tribes, Yoruba (39.0 %) and Igala (25.2 %)
were most highly represented. Nearly 85 % of the cus-
tomers lived in the same community as the PPMV shop
and over 60 % reported having a clinic near their home.
Most customers were purchasing drugs for a sick adult
(74.6 %), including for him/herself or for someone else
over 18. Among sick children (age 18 or under), 33 % were
present at the shop (equivalent to 8.4 % of the total sam-
ple). More customers self-reported headache (30.5 %) than
any other symptom, followed by fever (22.9 %), cough/cold
(18.1 %), and diarrhea (8.4 %).
PPMV and shop characteristics
The mean age of the person in charge at sampled PPMV
shops was 32.9 years, and more than half were male
(58.7 %). Less than 20 % of shop respondents reported
having any sort of formal medical training (i.e. doctor,
nurse, midwife, pharmacist or CHEW), but over half
(56.4 %) reported offering some type of test or exam.
Care-seeking behavior
Table 2 displays the customer care-seeking behavior out-
comes occurring prior to attending the PPMV shop. Over-
all, only 7.8 % of customers were diagnosed by a formally
trained person. In multivariate analysis (see Table 3), cus-
tomers reporting fever symptoms were more than twice as
likely to have been diagnosed compared to customers not
reporting fever (OR = 2.112; 95 % CI 1.428-3.123). In con-
trast, customers reporting headache or cough/cold symp-
toms were half as likely to have been diagnosed compared
to those not reporting these symptoms (OR = 0.645; 95 %
CI 0.427-0.974 and OR = 0.604; 95 % CI 0.366-0.997, re-
spectively). Customers over age 40 (OR = 1.973; 95 % CI
1.112-3.500) or in the highest two wealth quintiles (OR =
2.073; 95 % CI 1.205-3.567 and OR = 2.017; 95 % CI
1.142-3.563) were significantly more likely to be diagnosed
by a formally trained person. Customers with only primary
schooling were less likely to be diagnosed before the shop
visit (OR = 0.523; 95 % CI 0.284-0.964). Although only
marginally significant (p < 0.10), there was a slight increase
in likelihood of being diagnosed if the customer reported
living near a clinic (OR = 1.558; 95 % CI 0.999-2.430).
More than 65 % of customers waited two or more days
before visiting the PPMV shop (see Table 2). Symptoms
that predicted waiting longer included fever and cough/
cold symptoms (OR = 2.751; 95 % CI 2.082-3.636 and
OR = 2.055; 95 % CI 1.555-2.716, respectively), while
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customers reporting headache were less likely to wait
two or more days (OR = 0.567; 95 % CI 0.456-0.706) (see
Table 3). Customers in the lowest wealth quintile (OR =
1.725; 95 % CI 1.146-2.595) and those diagnosed by a
formally trained person were more likely to wait two or
more days before visiting the PPMV shop (OR = 3.556;
95 % CI 2.213-5.715).
Customer-PPMV attendant interactions
About 41 % of customers discussed the illness with the
shop worker (see Table 2). After controlling for cus-
tomer and PPMV shop worker characteristics in multi-
variate regression analysis, customers reporting fever or
cough/cold symptoms were more likely to discuss the ill-
ness than if none of these symptoms were reported (OR =
2.738; 95 % CI 2.119-3.539 and OR = 1.688; 95 % CI
1.294-2.202, respectively) (Table 4, column 1). However, if
the customer reported headache symptoms, they were less
likely to discuss the illness with the PPMV worker (OR =
0.786; 95 % CI 0.626-0.988).
Children (age 13-18) purchasing drugs were significantly
less likely to have a discussion about the illness with the
Table 1 Sample characteristics
Customer characteristics (N=2359) Number Percent









Educational attainment Primary 762 0.323
Secondary 1101 0.467
Higher 496 0.210










Lives in the community 1993 0.845
Has a clinic near home 1402 0.631
Sick person’s age <5 293 0.124
5-17 306 0.130
18+ 1760 0.746
Sick child (<18) is male 272 0.115




Has formal trainingb 49 0.198
Offers tests/exams 141 0.564
Location Urban 70 0.280
Peri-urban 85 0.340
Rural 95 0.380
State Kogi 124 0.496
Kwara 126 0.504
The denominator for each characteristic excludes missing or unknown values
aValues shown as mean (standard deviation)
bSelf-reported pharmacist, nurse, midwife, doctor or community health
extension worker
Table 2 Care-seeking outcomes
Care-seeking behavior N %
Diagnosed by a formally trained persona 185 0.078
Number of days sick before visiting a PPMV shop
0-1 days 811 0.344
2+ days 1548 0.656
Customer-PPMV interaction at the shop
Customer and PPMV discussed illness 972 0.412
Sick person was examined 172 0.073
Customer/family/friend recommended drugb 1153 0.489
Drugs purchased
Mean (SD) cost (Naira) 85.90 (3.13)





Customer had problems payingg 233 0.102
N 2359
SD = standard deviation
aCustomer responded to the question, “Who figured out what illness this is?”
Formally trained personnel include doctor/nurse, pharmacist, or community
health extension worker (CHEW) and exclude myself/relative/friend, lab
technician, chemist/PPMV, and traditional healers
bCustomer responded to question, “Who mainly recommended the drugs that
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shop worker than older customers aged 19-25 (OR = 0.631;
95 % CI 0.441-0.903) (see Table 4, column 1). Customers
with primary education were more likely to discuss the
illness compared to those with secondary schooling (OR =
1.580; 95 % CI 1.183-2.112). If the sick person was a child
and s/he was present at the shop, the odds of discussing
the illness was nearly five times higher than if s/he was not
present or over age 18 (OR = 4.739; 95 % CI 2.885-7.785).
Even though less than one-quarter of PPMV shop
workers interviewed reported having some formal medical
Table 3 Logistic regressions predicting the diagnosis by a formally trained person and time waited before visiting the PPMV
(odds ratios)
Diagnosed by a formally trained person Waited 2+ days before visiting the PPMV
OR 95 % CI OR 95 % CI
Symptoms reported
Fever (ref: no fever) 2.112*** [1.428 - 3.123] 2.751*** [2.082 - 3.636]
Diarrhea (ref: no diarrhea) 0.620 [0.298 - 1.288] 0.925 [0.640 - 1.335]
Headache (ref: no headache) 0.645** [0.427 - 0.974] 0.567*** [0.456 - 0.706]
Cough/cold (ref: no cough/cold) 0.604** [0.366 - 0.997] 2.055*** [1.555 - 2.716]
Male (ref: female) 1.063 [0.734 - 1.541] 0.982 [0.800 - 1.205]
Age (ref: 19-25)
13-18 0.720 [0.356 - 1.455] 0.815 [0.585 - 1.135]
26-40 1.343 [0.835 - 2.161] 1.004 [0.770 - 1.311]
41+ 1.973** [1.112 - 3.500] 1.092 [0.787 - 1.513]
Education (ref: secondary)
Primary 0.523** [0.284 - 0.964] 0.946 [0.711 - 1.259]
Higher 1.063 [0.681 - 1.658] 0.967 [0.724 - 1.292]
Tribe (ref: Ebira)
Fulani 1.144 [0.334 - 3.916] 0.655 [0.344 - 1.249]
Igala 0.685 [0.345 - 1.364] 0.622** [0.394 - 0.980]
Yoruba 0.528 [0.240 - 1.161] 0.805 [0.485 - 1.337]
Other 0.680 [0.344 - 1.346] 0.666* [0.416 - 1.068]
Wealth (ref: third quintile)
Poorest 0.421* [0.177 - 1.005] 1.725*** [1.146 - 2.595]
Second 0.866 [0.468 - 1.602] 1.186 [0.856 - 1.643]
Fourth 2.073*** [1.205 - 3.567] 0.793 [0.583 - 1.080]
Richest 2.017** [1.142 - 3.563] 1.149 [0.823 - 1.604]
Lives in community (ref: lives outside community) 0.724 [0.432 - 1.213] 1.027 [0.752 - 1.401]
Clinic near home (ref: no clinic near home) 1.558* [0.999 - 2.430] 0.977 [0.772 - 1.236]
Sick person age (ref: 18+)
<5 1.435 [0.780 - 2.640] 1.441* [0.952 - 2.181]
6-17 0.658 [0.327 - 1.323] 0.944 [0.663 - 1.345]
Sick person is male <18 (ref: female or 18+) 1.242 [0.640 - 2.412] 1.132 [0.737 - 1.740]
Diagnosed by formally trained person
(ref: not diagnosed by formally trained person)
3.556*** [2.213 - 5.715]
Kogi (ref: Kwara) 1.113 [0.549 - 2.257] 1.162 [0.785 - 1.719]
Location (ref: urban)
Peri-urban 1.384 [0.778 - 2.460] 0.972 [0.706 - 1.339]
Rural 1.392 [0.741 - 2.615] 1.324 [0.937 - 1.870]
N 2189 2189
ref = reference
***p < 0.01, ** p < 0.05, * p < 0.10
Standard errors are clustered at the shop level. 95 % confidence intervals in brackets
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Table 4 Logistic regressions predicting customer-PPMV interactions (odds ratios)




Ln (cost)a (4) Had problems
paying (5)
Symptoms reported
Fever (ref: no fever) 2.738*** 2.216*** 0.353*** 0.816*** 2.404***
[2.119 – 3.539] [1.397 – 3.516] [0.271 – 0.460] [0.717 – 0.915] [1.587 – 3.642]
Diarrhea
(ref: no diarrhea)
1.351 0.605 0.739 −0.225*** 0.990
[0.935 - 1.951] [0.251 - 1.462] [0.514 - 1.062] [-0.369 - -0.081] [0.526 - 1.861]
Headache
(ref: no headache)
0.786** 1.084 1.367*** −0.224*** 0.753
[0.626 - 0.988] [0.684 - 1.718] [1.096 - 1.706] [-0.311 - -0.137] [0.493 - 1.150]
Cough/cold
(ref: no cough/cold)
1.688*** 0.500** 0.686*** 0.323*** 1.969***
[1.294 - 2.202] [0.267 - 0.935] [0.528 - 0.891] [0.221 - 0.426] [1.263 - 3.071]
Age (ref: 19-25)
13-18 0.631** 0.420* 0.974 −0.281*** 0.418**
[0.441 – 0.903] [0.169 – 1.044] [0.699 – 1.355] [-0.412 - -0.151] [0.202 – 0.867]
26-40 1.282* 0.996 0.932 0.086 1.244
[0.981 – 1.674] [0.590 – 1.682] [0.716 – 1.213] [-0.017 – 0.189] [0.772 – 2.007]
41+ 1.367* 0.551* 0.906 0.135** 1.887**
[0.989 - 1.891] [0.291 - 1.044] [0.658 - 1.248] [0.009 - 0.261] [1.072 - 3.324]
Education (ref: secondary)
Primary 1.580*** 2.231*** 0.749** −0.060 1.062
[1.183 - 2.112] [1.262 - 3.942] [0.565 - 0.991] [-0.170 - 0.050] [0.652 - 1.730]
Higher 1.327* 1.248 0.972 0.063 0.488**
[0.996 - 1.770] [0.687 - 2.267] [0.729 - 1.295] [-0.048 - 0.175] [0.274 - 0.867]
Wealth (ref: third quintile)
Poorest 0.896 1.378 0.725 0.038 3.036***
[0.598 - 1.342] [0.620 - 3.061] [0.490 - 1.074] [-0.117 - 0.193] [1.569 - 5.874]
Second 1.034 0.836 0.690** 0.026 1.667*
[0.745 - 1.436] [0.417 - 1.675] [0.500 - 0.952] [-0.099 - 0.151] [0.949 - 2.929]
Fourth 1.119 0.871 0.690** 0.168*** 0.777
[0.813 - 1.540] [0.451 - 1.682] [0.505 - 0.943] [0.047 - 0.290] [0.415 - 1.455]
Richest 1.023 1.130 0.718** 0.279*** 0.866
[0.729 - 1.436] [0.559 - 2.284] [0.516 - 0.999] [0.151 - 0.408] [0.452 - 1.662]
Lives in community
(ref: lives outside community)
0.948 0.819 0.805 −0.202*** 1.145
[0.695 - 1.294] [0.452 - 1.486] [0.591 - 1.096] [-0.322 - -0.081] [0.677 - 1.935]
Clinic near home
(ref: no clinic near home)
1.047 1.430 0.988 0.056 1.021
[0.826 - 1.327] [0.860 - 2.378] [0.786 - 1.243] [-0.036 - 0.149] [0.665 - 1.567]
Sick person age (ref: 18+)
<5 0.890 0.452 0.855 0.455*** 2.240**
[0.579 – 1.368] [0.175 – 1.166] [0.554 – 1.321] [0.293 – 0.617] [1.194 – 4.202]
5-17 1.375* 0.839 0.823 0.210*** 1.538
[0.947 - 1.998] [0.355 - 1.985] [0.572 - 1.183] [0.070 - 0.350] [0.815 - 2.900]
Sick person is <18 and present at
PPMV (ref: not present or 18+)
4.739*** 23.400*** 0.224*** 0.323*** 2.063**
[2.885 - 7.785] [9.799 - 55.883] [0.131 - 0.383] [0.152 - 0.495] [1.094 - 3.891]
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training, over half (56.4 %) reported offering some sort of
test or exam for customers (Table 1). An examination was
observed in only 7.3 % of customer interactions (Table 2).
In multivariate analysis, the odds of being examined were
twice as high if fever was reported (OR = 2.216; 95 % CI
1.397-3.516) (Table 4, column 2). In contrast, customers
reporting cough/cold symptoms were less likely to be ex-
amined (OR = 0.500; 95 % CI 0.267-0.935), and not signifi-
cant association was detected for customers reporting
headache symptoms. Sick individuals were more likely to
be examined if they had only completed primary educa-
tion (OR = 2.231; 95 % CI 1.262-3.942) or if s/he was a
child present at the shop (OR = 23.400; 95 % CI 9.799-
55.883).
During the exit interview, nearly half of customers
(48.9 %) responded that they, another family member, or
a friend rather than a doctor/nurse, pharmacist, CHEW,
PPMV, or traditional healer recommended the drug pur-
chased (Table 2). If fever or cough/cold symptoms were
reported, the customer was less likely to select the drugs
him/herself (OR = 0.353; 95 % CI 0.271-0.460 and OR =
0.686; 95 % CI 0.528-0.891, respectively); however, if
headache was reported, the customer was more likely to do
so (OR = 1.367; 95 % CI 1.096-1.706) (Table 4, column 3).
Other characteristics associated with having a lower odds
of self-recommending the drug included having primary
education (OR = 0.749; 95 % CI 0.565-0.991), being in the
second, fourth, or fifth wealth quintiles (compared to the
middle quintile, OR = 0.690; 95 % CI 0.500-0.952, OR =
0.690; 95 % CI 0.505-0.943, and OR= 0.718; 95 % CI 0.516-
0.999, respectively), being diagnosed by a formally trained
person (OR = 0.072; 95 % CI 0.040-0.127), and purchasing
for a sick child brought to the shop (OR = 0.224; 95 % CI
0.131-0.383).
In additional sensitivity analyses in multivariate regres-
sions, we controlled for whether the PPMV worker was
the shop owner or an apprentice; no results were different.
Drug purchases
On average, customers spent 85.90 Naira (~US$0.52) on
drug purchases, which could include vitamins/supplements
and analgesics (Table 2). Different symptoms resulted in
vastly different sums spent on drugs. Customers reporting
fever spent an average of 203.71 Naira (~US$1.23), 111.37
Naira (~US$0.67) for those reporting cough/cold symp-
toms, 72.49 Naira (~US$0.44) for diarrhea, and 69.11 Naira
(~US$0.42) headache symptoms. In multivariate analysis,
fever was associated with spending 81.6 % more than
if no fever was reported (95 % CI 0.717-0.915), and
those experiencing cough/cold symptoms spent nearly
one-third more than if cough/cold was not experienced
( ^^β = 0.323; 95% CI 0.221-0.426) (Table 4, column 4).
Conversely, customers purchasing for diarrhea or head-
ache spent 22 % less than customers without those symp-
toms (95 % CI -0.369- -0.081 and -0.311- -0.137,
respectively).
Customers aged 13-18 spent 28.1 % less compared to
those age 19-25 (95 % CI -0.412- -0.151), while those over
age 40 spent 13.5 % more (95 % CI 0.009-0.261). Cus-
tomers in the two richest wealth quintiles spent 16.8 %
and 27.9 % more than customers in the middle wealth
quintile (95 % CI 0.047-0.290 and 0.151-0.408, respect-
ively), and if the customer lived in the same community as
the shop’s location, s/he spent 20.2 % less compared to
those living elsewhere (95 % CI -0.322- -0.081). More was
spent if the sick person was a child: 45.5 % more if the sick
person was under age five (95 % CI 0.293-0.617) and 21.0 %
more if s/he was age 5-17 (95 % CI 0.070-0.350). When
the sick child was brought to the shop, 32.3 % more was
spent (95 % CI 0.152-0.495). Being diagnosed by a formally
trained person before attending the shop was also associ-
ated with spending 66.9 % more (95 % CI 0.523-0.815).
About 10 % of customers reported difficulty paying for
their drug purchases (see Table 2). Symptoms associated
with a higher likelihood of payment difficulties included
fever (OR = 2.404; 95 % CI 1.587-3.642) and cough/cold
(OR = 1.969; 95 % CI 1.263-3.071), but not diarrhea or
headache (Table 4, column 5). Customers aged 13-18 were
less likely to have problems paying (OR = 0.418; 95 % CI
0.202-0.867) while those over age 40 were more likely
(OR = 1.887; 95 % CI 1.072-3.324). Fewer problems paying
was associated with higher education (OR = 0.488; 95 % CI
0.274-0.867), but greater difficulty paying was associated
with being in the poorest wealth quintile (OR = 3.036; 95 %
Table 4 Logistic regressions predicting customer-PPMV interactions (odds ratios) (Continued)
Sick person is male <18
(ref: female or 18+)
0.952 1.053 0.889 −0.125 0.557*
[0.629 - 1.440] [0.529 - 2.098] [0.583 - 1.354] [-0.277 - 0.027] [0.309 - 1.004]
Diagnosed by formally trained person
(ref: not diagnosed by formally trained person)
0.720* 1.627 0.072*** 0.669*** 1.466
[0.492 - 1.053] [0.844 - 3.139] [0.040 - 0.127] [0.523 - 0.815] [0.806 - 2.668]
N 2155 2154 2155 2152 2120
ref = reference
***p < 0.01, ** p < 0.05, * p < 0.10
95 % confidence intervals in brackets. Standard errors are clustered at the shop level. All regressions control for customer age and tribe, PPMV age, gender,
self-reported formal medical training, if PPMV offers tests/exams, state, and shop location (urban, peri-urban, or rural)
aOrdinary least squares analysis used
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CI 1.569-5.874), for caregivers purchasing for a sick child
under age five (OR = 2.240; 95 % CI 1.194-4.202), and if the
sick child was brought to the shop (OR = 2.063; 95 % CI
1.094-3.891).
Finally, the type of drugs purchased for different re-
ported symptoms was described (Fig. 1). Analgesics were
purchased in greatest quantity to treat a wide variety of
symptoms, including headache, fever, cough/cold, or other
symptoms such as sweating, nausea/vomiting, body aches/
joint pain, or chills/shivering. Although fewer of them
were purchased, vitamins/supplements and antibiotics
were also used to treat a wide variety of ailments. Most
customers (82 %) who purchased an ACT or other anti-
malarial reported fever symptoms and 82 % of customers
purchasing an anti-diarrhea product reported diarrhea
symptoms.
Discussion
Based on PPMV shop and customer surveys and observa-
tions in Kogi and Kwara states, Nigeria, the major symp-
toms for which customers (adults and children) seek care
at PPMV shops were fever, cough/cold, and diarrhea. The
prevalence of these symptoms was similar to what has
been previously reported among children at health facil-
ities in Nigeria [33–35]. However, this is the first study to
document that a similar prevalence of these symptoms ex-
ists among adults seeking care at PPMV shops.
Studies of individual care-seeking in many LMICs sug-
gests a complicated process according to a number of fac-
tors, including symptom [4, 33, 36], consultation with
household members [37–39], relying on prior experiences
[40], perceived severity of illness [41], quality of care, pro-
vider reputation [42, 43], cost [7, 38], location [44], and
use of multiple, concurrent treatments [4, 45, 46]. Our
study of care-seeking showed that PPMV customer be-
havior also varied by many of these factors. That cus-
tomers with fever were more likely to get diagnosed by
a formally trained person, discuss their symptoms with
and be examined by the shop worker, and less likely to
self-recommend purchased drugs suggests that cus-
tomers may perceive fever to be a more serious symp-
tom of illness than the other symptoms. In contrast,
customers with cough/cold or headache symptoms were
more likely to seek care in a way consistent with self-
treatment (i.e. less likely to be diagnosed by a formally
trained person and discuss the illness with the shop
worker or be examined, and more likely to select the
drug themselves) rather than consulting a provider.
Differences in care-seeking behavior were also ob-
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Fever + any other symptom
Fig. 1 Drug type purchased by reported symptom. The number of customers reporting different symptoms was plotted according to which type
of drug was purchased. Some customers purchased more than one drug type. Fever was often reported with other symptoms (such as headache,
cough/cold, or others) and all combinations of fever with other symptoms were grouped together. ACT = artemisinin-based combination therapy
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are substantial equity gaps in access to care, even
among individuals who seek care at informal providers.
Customers in the two richest wealth quintiles were more
than twice as likely to have sought care from a formally
trained provider before going to a PPMV shop compared
to customers in lower quintiles, with those in the poorest
quintile more likely to wait two or more days before seek-
ing care. Previous studies also show that poorer house-
holds in Nigeria are more likely to use informal private
providers [47] while richer households are more likely to
go to private clinics [48–50]. These differences by wealth
are likely be related to cost of care, which has also been
found to cause poorer households to delay care-seeking, at
both formal facilities and informal drug sellers [34, 40].
Evidence from this and other studies [44] also indicates
that distance can be a barrier to care-seeking: customers
living near a clinic were slightly more likely to have been
diagnosed by a formally trained provider.
While most of the care-seeking and customer-provider
interactions outcomes analyzed were similar for adults
and children, delayed care-seeking and improper diagno-
sis and treatment have more severe implications for chil-
dren given their high risk of mortality from common
illnesses. Only 8 % of customers captured in this study
were diagnosed by a formally trained person before visit-
ing the PPMV shop, akin to what other studies have
found [22, 34, 51]. Furthermore, when caregivers face fi-
nancial and distance-related barriers, and have difficulty
recognizing different illnesses or their severity, they are
more likely to try home or multiple treatments in an ef-
fort to “buy time” while they monitor disease progres-
sion [4, 19], delaying proper treatment [16, 40, 41, 51].
However, studies show that households may be more
willing to pay for higher quality drugs for children than
adults [43, 51], which was also the case in this study.
When seeking care for children, mothers have ranked
cost as less important than when seeking care for them-
selves [34]. Moreover, if the sick child was brought to
the PPMV shop, a discussion of the current illness epi-
sode and an exam was much more likely to occur, and
caregivers where less likely to rely on their own recom-
mendation for purchasing drug. This finding corrobo-
rates other studies in Nigeria which show that children
are more likely to receive “better” care than adults, al-
though improper treatment may still be high [51, 52]
and may oftentimes be irrational and lead to excessive
drug expenses [24]. It was difficult to discern any system-
atic patterns in drug purchases for different symptoms.
The large volume of analgesic and vitamin/supplement
sales accords with the regulatory scope of PPMVs as over-
the-counter drug sellers. Yet, customers tended to spend
more when purchasing drugs to treat fever and cough/
cold symptoms. Further, while most fevers were associated
with the purchase of anti-malarial drugs, not all were
artemisinin-based combination therapies (ACTs) recom-
mended by national treatment guidelines [49]. And since
PPMVs are not allowed to perform diagnostics [17, 53],
whether febrile and non-febrile illnesses were treated cor-
rectly cannot be determined [51, 54]. As such, many anti-
biotics were also purchased even though PPMVs are not
legally permitted to sell them, highlighting the influence
of both strong consumer demand for these drugs and
weak regulatory enforcement on PPMV dispensing. Over-
all, the lack of consistent dispensing among PPMVs may
be partly attributable to the fact that PPMVs are not re-
quired to undergo any formal pharmacy training, and
many may not have adequate knowledge of primary care
for the common illnesses they are presented with [55].
The findings from this study should be noted with sev-
eral limitations. Recruitment occurred at PPMV shops
that were part of a targeted, stratified random sample,
which may not be representative of all retail shops in the
area. Only shops in two states were used for recruit-
ment, and PPMV shops in other states may be used dif-
ferently. Care-seeking behavior in North Central Nigeria
may also not be representative of health behaviors in
other parts of the country. Most responses were self-
reported and there may be recall bias or other important
mediating factors, such as household decision-making dy-
namics over healthcare expenditures, which influence
care-seeking behaviors that were not observed. Although
surveyors did not engage with either the shop worker or
customer during the transaction, his/her presence alone
may have influence either to behave in a more socially de-
sirable manner, which may result in more favorable re-
sponses. The customer survey did not collect information
on treatment attempted before attending the PPMV shop,
so this aspect cannot be evaluated. Finally, no formal diag-
nosis was available for these customers so it was not pos-
sible to assess how care-seeking behavior changes based
on actual illness and not just symptoms. Without a diag-
nosis, the quality of care received at the PPMV shop could
not be evaluated, since receiving proper treatment could
not be measured. Although compensation gifts were not
given to the shop worker until the end of the survey day
to minimize response or behavior bias, we cannot rule out
the possibility that providers may have behaved differently
because of any perceived benefits of participation.
Conclusions
A variety of previous research on PPMV practice in
Nigeria has noted the generally poor quality of health
services delivered by these providers [25]. While im-
proper care-seeking may contribute to the lack of appro-
priate care, our research also shows that care-seeking
behavior depended on the symptoms experienced and
the sick person’s age, with fever symptoms and young
children given relatively more attention in terms of
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diagnosis, consultation, and speed. Other symptoms—
diarrhea, cough/cold, and headaches—received relatively
less attention, including circumventing formal diagnosis
and delayed care-seeking, which may exacerbate more se-
vere underlying illnesses, such pneumonia, which also sig-
nificantly contribute to child mortality in Nigeria [56].
Interventions to improve primary care should develop
basic guidelines for common illnesses, for both adults and
children. Caregivers of children with fever, diarrhea, and
headache symptoms should be seeking care promptly
given that the leading causes of death among children in
Nigeria stem from common preventable illnesses—
diarrhea, pneumonia, and malaria [56]. Given that care-
givers are often unable to recognize different illnesses,
interventions aimed at improving health outcomes for
children should target caregiver behavior change and in-
crease demand for diagnosis from a formally trained med-
ical provider before treatment. This includes bringing the
sick child to the shop in order to increase the likelihood of
a more thorough consultation, provided that the PPMV
worker is adequately trained to identify and assess child-
hood illnesses.
While not necessarily viewed as formal medical pro-
viders, training PPMVs to conduct some basic health
consultations, along with strong referral skills, may help
to provide better care for lower SES populations and
those living farther away from a health facility who are
more likely to use PPMVs in lieu of formal medical care.
Complementary approaches, that not only focus on for-
mal care through the existing primary care system, but
also on community-based, informal sources of care, may
help to achieve universal health coverage goals. However,
rationalization of current policies and treatment guide-
lines is needed to improve quality of care and dispensing
at PPMVs, including setting and enforcing standards
with respect to antibiotics, basic diagnostic tools, and
training that could help to guide drug selling practices.
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